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DOI 10.1016/j.chembiol.2010.07.004The Cornell University laboratories of
Watt Webb and Harold Craighead are
miles and climatologic worlds away
from Menlo Park, California, but without
them, the founders of Pacific Biosciences
(PacBio) may not be enjoying their current
wave of success—a success that is
poised to reach new levels later this year.
In late 2010, the company will make
commercially available its new Single
Molecule Real Time (SMRT) DNA se-
quencing system. This instrument repre-
sents the first third-generation sequencing
instrument to become publicly available.
As this article goes to press, the companyThe technology platform allows for real-time detection of
biological events at single molecule resolution.
-Joseph Puglisiis shipping the first of its DNA sequencers
to ten users for beta testing.
DNA Sequencing
DNA sequencing involves deciphering the
continuum of nucleotide bases that make
up a given DNA segment. Though early,
laborious techniques to accomplish this
task had been available since 1971, the
interest in sequencing picked up in
the late 1970s with the advent of the first
rapidDNAsequencing technology, known
as Sanger sequencing, after its inventor
Frederick Sanger. Continuous DNA se-
quencing of approximately 1,000 bases
can be achieved by this method. Things
really got interesting in 1990, when the
Human Genome Project was announced:
the large-scale effort to fully sequence the
entire human DNA sequence (genome).
Approximately 13 years and an estimated
cost of over 3 billion dollars were required
to churn out the first instance of a genome
3 billion nucleotides long.
To make the goal of routine genome
sequencing a reality, newer, faster tech-nologies are necessary. Second genera-
tion technologies have truly revolutionized
the field of DNA sequencing, genomics
research, and the understanding of
genome-related disease. These came in
the form of technologies introduced by
Roche (454 Life Sciences), Applied Bio-
systems (SOLiD), and Illumina (Genome
Analyzer); however, there were trade-
offs even with these newer systems,
mostly centered on the lack of reliable
lengths of base reads. Second-genera-
tion read lengths range from 30 up
to 450 bases, and the reliability of
these reads is lower than with Sangersequencing, introducing an inherent error
rate.
Zero-Mode Waveguide Technology
PacBio’s SMRT technology raises the
DNA sequencing bar. At the heart of
PacBio’s new DNA sequencing instru-
ment is zero-mode waveguide (ZMW)
technology, initially described in a 2003
Science paper coauthored by Webb and
Craighead (Levene et al., 2003).
‘‘ZMWs are tiny nanoholes, 70 nm in
diameter by 100 nm in depth, where a
single molecule of the DNA polymerase
enzyme can be placed to directly observe
it sequencing a strand of DNA,’’ explains
Eric Schadt, PacBio’s Chief Scientific
Officer. ‘‘We can multiplex that process
andobserve thisphenomenonas ithappens
over thousands or tens of thousands of
these holes simultaneously. The DNA
polymerase becomes the sequencing
engine. That is a true revolution.’’
In the late 1990s, under the tutelage of
Webb and Craighead, PacBio founders
Jonas Korlach and Stephen TurnerChemistry & Biology 17, July 30, 2010worked collaboratively on this initial tech-
nology (Levene et al., 2003). Today, they
are Vice President, and Chief Technology
Officer, respectively, at PacBio.
With PacBio’s SMRT technology, the
polymerase enzyme is affixed at the
bottom of a ZMW well. Using a single
DNA molecule as a template, the poly-
merase incorporates fluorescently labeled
DNA bases as it reads the template. Each
base has a different fluorescent dye,
thereby emitting a signal out of the ZMW.
A detector reads the fluorescent signal
and names the base based on the color
of the detected signal. Once the base is
added, the fluorescent tag is cleaved by
the polymerase.
At the time the technology was
announced, Craighead commented that
the ‘‘strategy is to eavesdrop on the natu-
rally occurring mechanisms for reading
DNA molecules while they do their work.’’
‘‘One of the principal challenges to
creating single nucleotide sequencing
capability is finding a way to exclude
unwanted background noise created by
the biological building materials that
must be present for this strategy to
work,’’ explains Turner. ‘‘The zero-mode
waveguide technology solves this prob-
lem for the first time.’’
Third Generation Essentials
‘‘Our viewpoint is that the third generation
has to bring the best of the first and
second generations forward: longer
sequenced read length, flexibility, and
quality of the first generationwith the lower
cost and higher throughput of second
generation,’’ says Turner. He explains
that the PacBio system produces se-
quenced read lengths up to 10,000 bases,
a full ten times higher compared with the
longest reads produced with Sanger
sequencing.
And it works more rapidly than second-
generation systems. ‘‘It is roughly 10,000–
20,000 times faster than the currentª2010 Elsevier Ltd All rights reserved 675
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taking an hour/nucleotide to sequence,
we are watching 1–3 nucleotides/
second.’’
The combination of quick time to result
and longer read lengths lends itself more
easily to the assembly of previously un-
known genomes, a process researchers
call de novo genome assembly.
Most of the sequencing happening
today in cancer genomes uses refer-
ence-based mapping to figure out what
changes in the tumor cells have occurred
to cause them to behave in a certain way.
‘‘But we know lots of things happen in
the tumor, like structural rearrangements
in the genome,’’ explains Schadt. ‘‘The
only way you can analyze that is a de
novo assembly, which our long read
lengths would allow you to do.’’
The technology platform allows for
real-time detection of biological events
at single-molecule resolution. ‘‘If you are
able to take things down to their most
fundamental unit of the molecule, that
gives you the best possible resolution of
what is going on,’’ says Schadt. This is
perhaps the main advantage of the
SMRT technology.
Many of today’s sequencing projects,
known as genome-wide association
studies (GWAS), involve the study of
many genomes to find genetic variants
linked to disease or any phenotype under
study. The PacBio technology is not aim-
ing to replace GWAS studies involving
comparative genomics on lots of people
or samples. ‘‘With single-molecule se-
quencing, we are extending that research
mission to be able to detect the raremuta-
tions between people in terms of health
down to themolecular level,’’ says Turner.
Mapping Chemical Modifications
The other significant feature of PacBio’s
SMRT technology involves a time dimen-
sion, but not just in terms of how fast
one can get results.
Because the technology allows the user
to watch the DNA polymerase in action in
real time, if the enzyme encounters any
chemical modification on the DNA bases
along the way, its kinetics change. ‘‘That
speaks to the epigenetic changes this
process finds that are very important for
regulation of the gene,’’ says Schadt.
The epigenome is a set of chemical modi-676 Chemistry & Biology 17, July 30, 2010 ª2fications surrounding the bases of the
DNA that have as much or more influence
on the gene’s activity as its sequence.
Common chemical modifications in-
clude methylation. As the sequencing
occurs, the polymerase enzyme kinetics
shift when it encounters a region of
methylation or any other base modifica-
tion. ‘‘If there are chemical modifications
on the bases of the DNA, like methylated
C residues or evidence of 8-oxoG from
DNA damage, the kinetics of the enzyme
will change when it encounters those
modified bases,’’ says Schadt. This infor-
mation is provided without extra proto-
cols like bisulfite treatments, which are
currently used to probe areas of methy-
lation.
When the enzyme encounters chemi-
cally modified bases, it will slow down or
speed up in a uniquely identifiable way.
The kinetic patterns are specific to
different modifications. ‘‘It isn’t just about
highlighting a region of interest. It actually
tells you what is there,’’ says Turner.
PacBio researchers published findings
onmethylation patterns inNatureMethods
(Flusberg et al., 2010). There they mapped
the kinetic patterns of three methylation
modifications:N6-methyladenine,5-methy-
lcytosine and 5-hydroxymethylcytosine.
‘‘The polymerase enzyme’s timing is
affected in subtle and very distinct ways,
so we can tell the difference, for example,
between a methylcytosine and a hydroxy-
methylcytosine in the same place and the
same context,’’ adds Turner.
Observing Protein Synthesis
The single-molecule real time platform
has shown applicability for nonsequenc-
ing efforts as well. PacBio collaborated
with Stanford University researcher
Joseph Puglisi to study the action of ribo-
somes, the body’s protein production
machinery. Puglisi’s lab works on the
basic mechanisms of how proteins are
made and the role of ribosomes in partic-
ular. Ribosomes translate RNA messages
to make proteins.
‘‘The limitation we always faced was
that in translation, you have to work at
very high concentrations of the substrates
in order to have translation occur effi-
ciently, at micromolar concentrations,’’
says Puglisi. With earlier single-molecule
technologies, he had to work with artifi-010 Elsevier Ltd All rights reservedcially lower fluorescently labeled sub-
strate concentrations to avoid back-
ground noise. His team had to work at
30–50 nM concentrations, a factor of
20–50-fold lower than the concentrations
that occur in the cell. He says, ‘‘It is just
not the right context in order to watch
protein synthesis.’’
With the SMRT technology, Puglisi
could observe translation in real time.
‘‘With this method, we can simultaneously
watch the ribosome performing its task
but also the underlying messenger RNA
sequence,’’ he explains. By using fluores-
cently dyed amino acids – the building
blocks of proteins – the instrument gives
off differing pulse colors as translation
occurs step by step (Uemura et al., 2010).
‘‘One of the biggest advantages of this
technology is being able to study biolog-
ical processes in real time at relevant
concentrations,’’ says Puglisi. ‘‘I believe
that studying dynamic behavior of bio-
logical systems is one of the frontiers
of us getting a full understanding of
how biology occurs from a chemical
perspective.’’
Beyond Genomics
‘‘Our technology is not just a DNA
sequencing paradigm,’’ says Turner. In
the future, he believes it will well serve
the integration of transcriptomics, epige-
nomics, genomics, metabolomics, clin-
ical annotation, and phenotype informa-
tion—a paradigm that is not fully
developed yet. ‘‘But that is where the
power to transform medicine lies,’’ he
says. ‘‘Our platform of looking at single
molecules in real time and the fluorescent
labeling of different biological systems is
broadly applicable and ideally suited for
that new environment.’’
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